These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 31402610)
1. A single-center SCN8A-related epilepsy cohort: clinical, genetic, and physiologic characterization. Zaman T; Abou Tayoun A; Goldberg EM Ann Clin Transl Neurol; 2019 Aug; 6(8):1445-1455. PubMed ID: 31402610 [TBL] [Abstract][Full Text] [Related]
2. The novel sodium channel modulator GS-458967 (GS967) is an effective treatment in a mouse model of SCN8A encephalopathy. Baker EM; Thompson CH; Hawkins NA; Wagnon JL; Wengert ER; Patel MK; George AL; Meisler MH; Kearney JA Epilepsia; 2018 Jun; 59(6):1166-1176. PubMed ID: 29782051 [TBL] [Abstract][Full Text] [Related]
3. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications. Johannesen KM; Liu Y; Koko M; Gjerulfsen CE; Sonnenberg L; Schubert J; Fenger CD; Eltokhi A; Rannap M; Koch NA; Lauxmann S; Krüger J; Kegele J; Canafoglia L; Franceschetti S; Mayer T; Rebstock J; Zacher P; Ruf S; Alber M; Sterbova K; Lassuthová P; Vlckova M; Lemke JR; Platzer K; Krey I; Heine C; Wieczorek D; Kroell-Seger J; Lund C; Klein KM; Au PYB; Rho JM; Ho AW; Masnada S; Veggiotti P; Giordano L; Accorsi P; Hoei-Hansen CE; Striano P; Zara F; Verhelst H; Verhoeven JS; Braakman HMH; van der Zwaag B; Harder AVE; Brilstra E; Pendziwiat M; Lebon S; Vaccarezza M; Le NM; Christensen J; Grønborg S; Scherer SW; Howe J; Fazeli W; Howell KB; Leventer R; Stutterd C; Walsh S; Gerard M; Gerard B; Matricardi S; Bonardi CM; Sartori S; Berger A; Hoffman-Zacharska D; Mastrangelo M; Darra F; Vøllo A; Motazacker MM; Lakeman P; Nizon M; Betzler C; Altuzarra C; Caume R; Roubertie A; Gélisse P; Marini C; Guerrini R; Bilan F; Tibussek D; Koch-Hogrebe M; Perry MS; Ichikawa S; Dadali E; Sharkov A; Mishina I; Abramov M; Kanivets I; Korostelev S; Kutsev S; Wain KE; Eisenhauer N; Wagner M; Savatt JM; Müller-Schlüter K; Bassan H; Borovikov A; Nassogne MC; Destrée A; Schoonjans AS; Meuwissen M; Buzatu M; Jansen A; Scalais E; Srivastava S; Tan WH; Olson HE; Loddenkemper T; Poduri A; Helbig KL; Helbig I; Fitzgerald MP; Goldberg EM; Roser T; Borggraefe I; Brünger T; May P; Lal D; Lederer D; Rubboli G; Heyne HO; Lesca G; Hedrich UBS; Benda J; Gardella E; Lerche H; Møller RS Brain; 2022 Sep; 145(9):2991-3009. PubMed ID: 34431999 [TBL] [Abstract][Full Text] [Related]
4. Aberrant Sodium Channel Currents and Hyperexcitability of Medial Entorhinal Cortex Neurons in a Mouse Model of Ottolini M; Barker BS; Gaykema RP; Meisler MH; Patel MK J Neurosci; 2017 Aug; 37(32):7643-7655. PubMed ID: 28676574 [No Abstract] [Full Text] [Related]
5. De novo and inherited SCN8A epilepsy mutations detected by gene panel analysis. Butler KM; da Silva C; Shafir Y; Weisfeld-Adams JD; Alexander JJ; Hegde M; Escayg A Epilepsy Res; 2017 Jan; 129():17-25. PubMed ID: 27875746 [TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlations in Polish patients with SCN8A-related epilepsy: A multicentre observational study. Paprocka J; Steinborn B; Krygier M; Winczewska-Wiktor A; Przyslo L; Hutny M; Hoffman-Zacharska D; Mazurkiewicz H; Kochanowska I; Zebrowska J; Zawadzka M; Piasecki L; Mazurkiewicz-Beldzinska M Seizure; 2024 Aug; 120():201-209. PubMed ID: 39047613 [TBL] [Abstract][Full Text] [Related]
7. SCN8A mutations in Chinese children with early onset epilepsy and intellectual disability. Kong W; Zhang Y; Gao Y; Liu X; Gao K; Xie H; Wang J; Wu Y; Zhang Y; Wu X; Jiang Y Epilepsia; 2015 Mar; 56(3):431-8. PubMed ID: 25785782 [TBL] [Abstract][Full Text] [Related]
8. Prax330 reduces persistent and resurgent sodium channel currents and neuronal hyperexcitability of subiculum neurons in a mouse model of SCN8A epileptic encephalopathy. Wengert ER; Saga AU; Panchal PS; Barker BS; Patel MK Neuropharmacology; 2019 Nov; 158():107699. PubMed ID: 31278928 [TBL] [Abstract][Full Text] [Related]
9. Variant-specific changes in persistent or resurgent sodium current in SCN8A-related epilepsy patient-derived neurons. Tidball AM; Lopez-Santiago LF; Yuan Y; Glenn TW; Margolis JL; Clayton Walker J; Kilbane EG; Miller CA; Martina Bebin E; Scott Perry M; Isom LL; Parent JM Brain; 2020 Oct; 143(10):3025-3040. PubMed ID: 32968789 [TBL] [Abstract][Full Text] [Related]
10. Clinical severity is correlated with age at seizure onset and biophysical properties of recurrent gain of function variants associated with SCN8A-related epilepsy. Chung KM; Hack J; Andrews J; Galindo-Kelly M; Schreiber J; Watkins J; Hammer MF Epilepsia; 2023 Dec; 64(12):3365-3376. PubMed ID: 37585367 [TBL] [Abstract][Full Text] [Related]
11. Biallelic inherited SCN8A variants, a rare cause of SCN8A-related developmental and epileptic encephalopathy. Wengert ER; Tronhjem CE; Wagnon JL; Johannesen KM; Petit H; Krey I; Saga AU; Panchal PS; Strohm SM; Lange J; Kamphausen SB; Rubboli G; Lemke JR; Gardella E; Patel MK; Meisler MH; Møller RS Epilepsia; 2019 Nov; 60(11):2277-2285. PubMed ID: 31625145 [TBL] [Abstract][Full Text] [Related]
14. Phenotypic and genetic spectrum in Chinese children with SCN8A-related disorders. Hu C; Luo T; Wang Y Seizure; 2022 Feb; 95():38-49. PubMed ID: 34979445 [TBL] [Abstract][Full Text] [Related]
15. Genetic and clinical features of SCN8A developmental and epileptic encephalopathy. Kim HJ; Yang D; Kim SH; Kim B; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC Epilepsy Res; 2019 Dec; 158():106222. PubMed ID: 31675620 [TBL] [Abstract][Full Text] [Related]
16. A multi-disciplinary clinic for SCN8A-related epilepsy. Schreiber JM; Tochen L; Brown M; Evans S; Ball LJ; Bumbut A; Thewamit R; Whitehead MT; Black C; Boutzoukas E; Fanto E; Suslovic W; Berl M; Hammer M; Gaillard WD Epilepsy Res; 2020 Jan; 159():106261. PubMed ID: 31887642 [TBL] [Abstract][Full Text] [Related]
17. Phenotypic and genetic spectrum of SCN8A-related disorders, treatment options, and outcomes. Gardella E; Møller RS Epilepsia; 2019 Dec; 60 Suppl 3():S77-S85. PubMed ID: 31904124 [TBL] [Abstract][Full Text] [Related]
18. De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy. Blanchard MG; Willemsen MH; Walker JB; Dib-Hajj SD; Waxman SG; Jongmans MC; Kleefstra T; van de Warrenburg BP; Praamstra P; Nicolai J; Yntema HG; Bindels RJ; Meisler MH; Kamsteeg EJ J Med Genet; 2015 May; 52(5):330-7. PubMed ID: 25725044 [TBL] [Abstract][Full Text] [Related]
19. Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach. Boerma RS; Braun KP; van den Broek MP; van Berkestijn FM; Swinkels ME; Hagebeuk EO; Lindhout D; van Kempen M; Boon M; Nicolai J; de Kovel CG; Brilstra EH; Koeleman BP Neurotherapeutics; 2016 Jan; 13(1):192-7. PubMed ID: 26252990 [TBL] [Abstract][Full Text] [Related]
20. A comprehensive approach to identifying repurposed drugs to treat SCN8A epilepsy. Atkin TA; Maher CM; Gerlach AC; Gay BC; Antonio BM; Santos SC; Padilla KM; Rader J; Krafte DS; Fox MA; Stewart GR; Petrovski S; Devinsky O; Might M; Petrou S; Goldstein DB Epilepsia; 2018 Apr; 59(4):802-813. PubMed ID: 29574705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]